Cardiac MRI is complementary to echocardiography in the assessment of cardiac masses

Echocardiography

Volumn 24, Issue 3, 2007, Pages 286-300

  Altbach, Maria I ^a   Squire, Scott W ^a   Kudithipudi, Vijayasree ^a   Castellano, Lisa ^a   Sorrell, Vincent L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cardiac CT; Cardiac MRI; Contrast; Echocardiography; Gadolinium; Mass

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

CANCER SURGERY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FIBROELASTOMA; FIBROMA; HEART ATRIUM FIBRILLATION; HEART MYXOMA; HEART SARCOMA; HEART TUMOR; HEMANGIOMA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING SYSTEM; INTRACARDIAC THROMBOSIS; LIPOMA; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIUM CYST; PRIORITY JOURNAL; REVIEW; RHABDOMYOMA; RISK ASSESSMENT; THROMBOEMBOLISM; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HEART NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; PREVALENCE;

EID: 33847091251     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00392.x     Document Type: Review

References (73)

1. Zipes DP, Libby P, Bonow RO, et al: Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine, 7th Ed., Vol 2. Philadelphia: Elsevier Saunders, 2005, p.1746.
2. Roberts WC: Primary and secondary neoplasms of the heart. Am J Cardiol 1997;80:671-682.
3. Butany J, Nair V, Naseemuddin A, et al: Cardiac tumours: Diagnosis and management. Lancet Oncol 2005;6:219-228.
4. Lam KY, Dickens P, Chan AC: Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993;117:1027-1031.
5. Basso C, Valente M, Poletti A, et al: Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg 1997;12:730-738.
6. Bjessmo S, Ivert T: Cardiac myxoma: 40 years' experience in 63 patients. Ann Thorac Surg 1997;63:697-700.
7. Sarjeant JM, Butany J, Cusimano RJ: Cancer of the heart: Epidemiology and management of primary neoplasms and metastases. Am J Cardiovasc Drugs 2003;3:407-421.
8. Araoz PA, Mulvagh SL, Tazelaar HD, et al: CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 2000;20:1303-1319.
9. Carney JA, Gordon H, Carpenter PC, et al: The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 1985;64:270-283.
10. Burke A, Virmani R: Tumors of the heart and great vessels. In: Atlas of Tumor Pathology, Fascicle 16, Series 3. Washington, DC, Armed Forces Institute of Pathology, 1996, pp. 1-98.
11. Tazelaar HD, Locke TJ, McGregor CG: Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc 1992;67:957-965.
12. Shapiro LM: Cardiac tumours: Diagnosis and management. Heart 2001;85:218-222.
13. Loire R, Donsbeck AV, Nighoghossian N, et al: Papillary fibroelastoma of the heart. A review of 20 cases. Arch Anat Cytol Pathol 1999;47:19-25.
14. Grinda JM, Couetil JP, Chauvaud S, et al: Cardiac valve papillary fibroelastoma: Surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg 1999;117:106-110.
15. Grande AM, Minzioni G, Pederzolli C: Cardiac lipomas description in three cases. J Cardoivasc Surg 1998;39:813-815.
16. Beghetti M, Gow RM, Haney I, et al: Pediatric primary benign cardiac tumors: A 15-year review. Am Heart J 1997;134:1107-1114.
17. Webb DW, Thomas RD, Osborne JP: Cardiac rhabdomyomas and their association with tuberous sclerosis. Arch Dis Child 1993;68:367-370.
18. McAllister HA Jr, Fenoglio JJ Jr: Tumors of the cardiovascular system. Atlas of tumor pathology, 2nd series. Fascicle 15 Washington, D.C. Armed Forces Institute of Pathology, 1978:1-20.
19. Herrmann MA, Shankerman RA, Edwards WD, et al: Primary cardiac angiosarcoma: A clinicopathologic study of six cases. J Thorac Cardiovasc Surg 1992;103:655-664.
20. Grebenc ML, Rosado de Christenson ML, Burke AP, et al: Primary cardiac and pericardial neoplasms: Radiologic-pathologic correlation. Radiographics 2000;20:1073-1103.
21. Murphy MC, Sweeney MS, Putnam JB Jr, et al: Surgical treatment of cardiac tumors: A 25-year experience. Ann Thorac Surg 1990;49:612-618.
22. Schvartzman PR, White RD: Imaging of cardiac and paracardiac masses. J Thorac Imaging 2000;15:4265-4273.
23. Rickers C, Wilke NM, Jerosch-Herold M, et al: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-861.
24. Maron BJ, Dearani JA, Ommen SR, et al: The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2044-2053.
25. Macedo R, Schmidt A, Rochitte CE, et al: MRI to assess arrhythmia and cardiomyopathies: Relationship to echocardiography. Echocardiography 2007;24:194-206.
26. Gaerte SC, Meyer CA, Winer-Muram HT, et al: Fat-containing lesions of the chest. Radiographics 2002;22(Suppl):61-78.
27. Rose P, Punjabi N, Pearse D: Treatment of right heart thromboemboli. Chest 2002;121:806.
28. Pauliks LB, Miller S, Banerjee A: Intracardiac fibroma in nevoid-basal cell carcinoma (gorlin) syndrome: Tissue characterization by strain rate imaging. Echocardiography 2006;23:79-80.
29. Kirkpatrick JN, Wong T, Bednarz JE, et al: Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol 2004;43:1412-1419.
30. Saric M, Applebaum RM, Culliford AT, et al: Massive atrial septal lipomatous hypertrophy. Echocardiography 1999;16:833-834.
31. Restrepo CS, Largoza A, Lemos DF, et al: CT and MR imaging findings of malignant cardiac tumors. Curr Probl Diagn Radiol 2005;34:1-11.
32. Restrepo CS, Largoza A, Lemos DF, et al: CT and MR imaging findings of benign cardiac tumors. Curr Probl Diagn Radiol 2005;34:12-21.
33. Simonetti OP, Finn JP, White RD, et al: "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199:49-57.
34. Barkhausen J, Ruehm SG, Goyen M, et al: MR evaluation of ventricular function: True fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: Feasibility study. Radiology 2001;219:264-269.
35. Dall'Armellina E, Hamilton CA, Hundley WG: Assessment of blood flow and valvular heart disease using phase-contrast cardiovascular magnetic resonance. Echocardiography 2007;24:207-216.
36. Funari M, Fujita N, Peck WW, et al: Cardiac tumors: assessment with Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:953-958.
37. Veinot JP, O'Murchu B, Tazelaar HD, et al: Cardiac fibroma mimicking apical hypertrophic cardiomyopathy: A case report and differential diagnosis. J Am Soc Echocardiogr 1996;9:94-99.
38. Burke AP, Rosado-de-Christenson M, Templeton PA, et al: Cardiac fibroma: Clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg 1994;108:862-870.
39. Hoffmann U, Globits S, Frank H: Cardiac and paracardiac masses. Current opinion on diagnostic evaluation by magnetic resonance imaging. Eur Heart J 1998;19:553-963.
40. Schoen FJ, Berger BM, Guerina NG: Cardiac effects of noncardiac neoplasms. Cardiol Clin 1984;2:657-670.
41. Maillard SM, Jones R, Owens C, et al: Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004;43:603-608.
42. Marie PY, Angioi M, Carteaux JP, et al: Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. Heart Transplant 2001;37:825-831.
43. Fenlon HM, Tello R, deCarvalho VL, et al: Signal characteristics of focal liver lesions on double echo T2-weighted conventional spin echo MRI: Observer performance versus quantitative measurements of T2 relaxation times. J Comp Assist Tomogr 2000;24:204-211.
44. Menon RS, Rusinko MS, Allen PS: Multiexponential proton relaxation in model cellular systems. Magn Reson Med 1991;20:196-213.
45. Yacoe ME, Bergman AG, Ladd AL, et al: Dupuytren's contracture: MR imaging findings and correlation between MR signal intensity and cellularity of lesions. Am J Roentgenol 1993;160:813-817.
46. Christensen DR, Ramsamooj R, Gilbert TJ: Sclerosing epithelioid fibrosarcoma: Short T2 on MR imaging. Skeletal Radiol 1997;26:619-621.
47. Ghugre NR, Coates TD, Nelson MD, et al: Mechanisms of tissue-iron relaxivity: Nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005;54:1185-1193.
48. Anderson LJ, Holden S, Davis B, Prescott E, et al: Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
49. Jerosch-Herold M, Seethamraju RT, Swingen CM, et al: Analysis of myocardial perfusion MRI. J Magn Reson Imaging 2004;19:758-770.
50. Higgins DM, Ridgway JP, Radjenovic A, et al: T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys 2005;32:1738-1746.
51. Messroghli DR, Radjenovic A, Kozerke S, et al: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-146.
52. Westwood M, Anderson LJ, Firmin DN, et al: A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
53. Altbach MI, Outwater EK, Trouard TP, et al: A radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver. J Magn Reson Imaging 2002;16:179-189.
54. Altbach MI, Bilgin A, Li Z, et al: Processing of radial fast-spin echo data for obtaining T2 estimates from a single K-space data set. Magn Reson Med 2005;54:549-559.
55. Altbach MI, Li Z, Bilgin A, et al: A novel radial MRI technique for obtaining high-resolution images of the heart with variable contrast from a single k-space data set. J Cardiovasc Magn Reson 2004;6:91-92.
56. Squire SW, Sorrell VL, Li Z, et al: A method for the fast T2 measurement of cardiac masses. Proc Int Soc Magn Reson Med 2005;13:1670.
57. Henkelman RM, Stanisz GJ, Graham SJ: Magnetization transfer in MRI: A review. NMR Biomed 2001;14:57-64.
58. Stanisz GJ, Odrobina EE, Pun J, et al: T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-512.
59. Nakae I, Mitsunami K, Matsuo S, et al: Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy. Circulation J 2005;69:711-716.
60. Bottomley PA, Weiss RG: Human cardiac spectroscopy. Magma 1998;6:157-160.
61. Di Costanzo A, Trojsi F, Tosetti M, et al: High-field proton MRS of human brain. Eur J Rad 2003;48:146-153.
62. Katz-Brull R, Rofsky NM, Lenkinski RE: Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med 2003;50:461-467.
63. Spuentrup E, Fausten B, Kinzel S, et al: Molecular magnetic resonance imaging of atrial clots in a swine model. Circulation 2005;112:396-399.
64. Haacke EM, Patrick JL: Reducing motion artifacts in two-dimensional Fourier transform imaging. Magn Reson Imaging 1986;4:359-376.
65. McConnell MV, Khasgiwala VC, Savord BJ, et al: Comparison of respiratory suppression methods and navigator locations for MR coronary angiography. Am J Roentgenol 1997;168:1369-1375.
66. Spuentrup E, Mahnken AH, Kuhl HP, et al: Fast interactive real-time magnetic resonance imaging of cardiac masses using spiral gradient echo and radial steady-state free precession sequences. Invest Radiol 2003;38:288-292.
67. Spuentrup E, Katoh M, Buecker A, et al: Free-breathing 3D steady-state free precession coronary MR angiography with radial k-space sampling: comparison with cartesian k-space sampling and cartesian gradient-echo coronary MR angiography. Radiology 2004;23:581-586.
68. Shetty A: Suppression of radiofrequency interference in cardiac gated MRI: A simple design. Magn Reson Med 1988;8:84-88.
69. Fischer S, Wickline S, Lorenz C: Novel real-time r-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance applications. Magn Reson Med 1999;47:361-370.
70. Larson AC, White RD, Laub G, et al: Self-gated cardiac cine MRI. Magn Reson Med 2004;51:93-102.
71. Martin ET, Coman JA, Shellock FG, et al: Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-1324.
72. Roguin A, Zviman MM, Meininger GR, et al: Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: In vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475-482.
73. Connelly PR, Kwok WE, Gray RW, et al: Susceptibility and RF-inhomogeneity artifacts of nanoparticulate coatings for intraluminal guide wires and catheters. Proc Int Soc Magn Reson Med 2005;11:1179.